Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Eberlein

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
JAMA|May 2, 1990
Biopsy of occult breast lesions. Analysis of 1261 abnormalitiesJ E Meyer, T J Eberlein, P C Stomper, et al.
Transplantation|November 1, 1983
Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell linesB Kim, M Rosenstein, D Weiland, et al.
Annals of Surgery|February 1, 1994
Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcomaS Singer, J M Corson, R Gonin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancerI Yoshino, G E Peoples, P S Goedegebuure, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cellsS Blotnick, G E Peoples, M R Freeman, et al.
International Journal of Cancer|February 6, 1999
Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cellsM Nagoshi, N Sadanaga, H G Joo, et al.
Cancer Research|November 26, 1997
Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.
American Journal of Surgery|September 1, 1991
Results of radical radiotherapy for inflammatory breast cancerC C Lamb, T J Eberlein, L M Parker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.
International Journal of Cancer|December 18, 2001
Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
JAMA|May 2, 1990
Biopsy of occult breast lesions. Analysis of 1261 abnormalitiesJ E Meyer, T J Eberlein, P C Stomper, et al.
Transplantation|November 1, 1983
Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell linesB Kim, M Rosenstein, D Weiland, et al.
Annals of Surgery|February 1, 1994
Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcomaS Singer, J M Corson, R Gonin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancerI Yoshino, G E Peoples, P S Goedegebuure, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cellsS Blotnick, G E Peoples, M R Freeman, et al.
International Journal of Cancer|February 6, 1999
Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cellsM Nagoshi, N Sadanaga, H G Joo, et al.
Cancer Research|November 26, 1997
Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.
American Journal of Surgery|September 1, 1991
Results of radical radiotherapy for inflammatory breast cancerC C Lamb, T J Eberlein, L M Parker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.
International Journal of Cancer|December 18, 2001
Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.
Pageof 10